MOXATAG Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Moxatag, and when can generic versions of Moxatag launch?
Moxatag is a drug marketed by Pragma and is included in one NDA. There are three patents protecting this drug.
This drug has eleven patent family members in six countries.
The generic ingredient in MOXATAG is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Moxatag
A generic version of MOXATAG was approved as amoxicillin by TEVA on December 22nd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MOXATAG?
- What are the global sales for MOXATAG?
- What is Average Wholesale Price for MOXATAG?
Summary for MOXATAG
International Patents: | 11 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Clinical Trials: | 1 |
Patent Applications: | 4,435 |
Drug Prices: | Drug price information for MOXATAG |
DailyMed Link: | MOXATAG at DailyMed |
Recent Clinical Trials for MOXATAG
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Nationwide Children's Hospital | N/A |
US Patents and Regulatory Information for MOXATAG
MOXATAG is protected by three US patents.
Patents protecting MOXATAG
Pharmaceutical compositions and methods for improved bacterial eradication
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF ONCE-A-DAY AMOXICILLIN PRODUCT TO TREAT TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES
Compositions and methods for improved efficacy of penicillin-type antibiotics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Modified release amoxicillin products
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MOXATAG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MOXATAG
See the table below for patents covering MOXATAG around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2010511607 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 2004012704 | ⤷ Sign Up | |
China | 101563466 | Modified release amoxicillin products | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2008069806 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |